Figure 1 – Share of applications with 3(d) objections in first examination report
Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/
Copyright © DrugPatentWatch. Originally published at
Subscribe to Free Updates3,000+ other biopharma execs get our Drug Patent Expiration Alerts. You should too!
Get fresh news and insights, drug patent expirations & more…